Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc.
July 29, 2024 07:35 ET
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced the signing of a co-promotion agreement with Kowa Pharmaceuticals America, Inc.
Claritas HealthTech Announces Spin-Off of Claritas NucMed Technologies Ltd to Lead Global Delivery of its Suite of Software Solutions in Nuclear Medicine
July 29, 2024 07:30 ET
|
Claritas HealthTech Ltd
Claritas HealthTech Announces Spin-Off of Claritas NucMed Technologies Ltd to Lead Global Delivery of its Suite of Software Solutions in Nuclear Medicine
Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results
July 29, 2024 07:02 ET
|
Ocugen
MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE
July 26, 2024 12:11 ET
|
Pomerantz LLP
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. (“Skye” or the “Company”) (NASDAQ: SKYE). Such investors are...
Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024
July 26, 2024 08:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second quarter...
United States Intraocular Lens Market Set for Expansion by 2032, Reveals In-Depth Market Analysis
July 26, 2024 07:23 ET
|
Research and Markets
Dublin, July 26, 2024 (GLOBE NEWSWIRE) -- The "United States Intraocular Lens Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032" report has been added to ...
EssilorLuxottica: Q2/H1 2024 Results - Sound revenue growth, margins expanding, two acquisitions in line with strategy
July 25, 2024 12:00 ET
|
EssilorLuxottica
Q2/H1 2024 Results Sound revenue growth, margins expanding, two acquisitions in line with strategy Revenue growing by 5.2% in Q2 at constant exchange rates1, +5.3% in H1EMEA as the driving region,...
Ocugen, Inc. Announces Completion of Dosing in Subjects with Geographic Atrophy Secondary to dAMD in High-Dose Cohort of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Novel Modifier Gene Therapy
July 25, 2024 06:30 ET
|
Ocugen
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
[Latest] US Fitness Tracker Market Size/Share Worth USD 35.8 Billion by 2033 at a 15.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 25, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, July 25, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Fitness Tracker Market Size, Trends and Insights By Type (Smart Watches,...
Nicox : Recrutement du dernier patient aux Etats- Unis dans l’étude clinique de phase 3 Denali sur NCX 470
July 25, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox : Recrutement du dernier patient aux Etats-Unis dans l’étude clinique de phase 3 Denali sur NCX 470 Le recrutement se poursuit en Chine, avec les premiers résultats...